Mona Stein Legator

Title: Innovations by Mona Stein Legator

Introduction

Mona Stein Legator is an accomplished inventor based in Evanston, IL (US). She has made significant contributions to the field of medical diagnostics, particularly in the area of lung cancer. Her work focuses on improving patient outcomes through innovative diagnostic methods.

Latest Patents

Mona holds 1 patent for her invention titled "Detection of chromosomal abnormalities associated with prognosis of non-small cell lung cancer." This patent addresses the critical need for a diagnostic method that can be provided to patients with early-stage lung cancer, especially non-small cell lung cancer (NSCLC). The methods and compositions described in her patent allow for more informed treatment decisions for early-stage lung cancer patients, helping to determine whether they are at increased risk of poor disease outcomes.

Career Highlights

Mona is currently employed at Abbott Molecular Inc., where she continues to work on innovative solutions in the field of molecular diagnostics. Her expertise and dedication to improving cancer diagnostics have made her a valuable asset to her team and the broader medical community.

Collaborations

Mona collaborates with talented professionals in her field, including Ekaterina Pestova and Xin Lu. These collaborations enhance the research and development of diagnostic methods that can significantly impact patient care.

Conclusion

Mona Stein Legator's contributions to the field of lung cancer diagnostics exemplify the importance of innovation in medicine. Her work not only advances scientific knowledge but also has the potential to improve the lives of countless patients facing lung cancer.